Wis. Admin. Code Controlled Substances Board CSB 2.25

Current through December 30, 2024
Section CSB 2.25 - Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil
(1) Section 961.16(3) (cm), Stats., is amended to read:
(cm) Carfentanil;
(2) Section 961.16(3) (xm), Stats., is created to read:
(xm) Remifentanil;
(3) Section 961.16(10) (a), Stats., is repealed.
(4) Section 961.18(4m), Stats., is created to read:
(4m) Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6aR-trans)-6a, 7, 8, 10a-tetrahydro-6, 6. 9-trimethyl-3-pentyl-6H-dibenzo(b, d)pyran-1-ol, and (-)-delta-9-(trans)-tetrahydrocannabinol.)
(5) Section 961.20(2) (o) and (p), Stats., is created to read:
(o) Zaleplon.
(p) Zolpidem.
(6) Section 961.20(2m) (at), (bu) and (f), Stats., is created to read:
(at) Fenproporex.
(bu) Modafinil.
(f) Sibutramine.

Wis. Admin. Code Controlled Substances Board CSB 2.25

CR Register, July, 2000, No. 535, eff. 8-1-00.